Brian R. Farnan

Brian R. Farnan is a patent litigator at Farnan LLP, where he primarily serves as Delaware counsel in complex litigation. His practice encompasses a wide range of patent disputes, notably in the pharmaceutical and technology sectors. While the firm frequently acts as local Delaware counsel for patent-holding claimant corporations, Mr. Farnan is particularly recognized for his extensive experience representing plaintiffs in patent litigation.

Mr. Farnan has been involved in significant patent cases, including serving as local counsel for the defendant in Veloxis Pharmaceuticals Inc. v. Sun Pharmaceutical Industries Ltd. He also represented generic drugmaker Cipla Ltd. alongside co-counsel in Amgen Inc. v. Cipla Ltd., where a Delaware federal judge ruled in favor of Cipla, preventing Amgen from halting sales of a generic version of its Sensipar drug. His litigation experience extends to trade secret, commercial, and bankruptcy matters, and he has tried numerous jury and bench trials in Delaware's federal and state courts.

There is no specific information available from reliable public sources indicating regular appearances by Mr. Farnan in PTAB or IPR proceedings.

Mr. Farnan earned his J.D. from Wake Forest University in 2001, following a B.A., cum laude, from Dickinson College in 1998. He is admitted to practice in Delaware, New Jersey, and Pennsylvania.